ELVN: enliventherapeutics.com Net earnings per share for the last 12 months

Symbol and logo of brand Enliven Therapeutics, Inc. (ELVN)

Enliven Therapeutics management remains stable, focusing on early-stage research and liquidity preservation. Enliven Therapeutics is implementing innovative kinase inhibitors to combat tumor resistance, with production based on outsourcing through reliable CMO partners. The company's specific annual income metric on the GURU.Markets platform chart demonstrates a consolidation phase, where the -1.71 level reflects the current state of earnings per share.

ELVN (Enliven Therapeutics) Net earnings per share (EPS TTM) history from 04/28/2023 to 11/18/2026

Analytical breakdowns for Enliven Therapeutics

Basic company analysis:Enliven Therapeutics - ELVN
Manufactured products of Enliven Therapeutics Inc

The active recruitment of rare targeted therapy specialists and the retention of core scientists through stock options are placing a significant strain on the operating budget of Enliven Therapeutics (ELVN). The rolling per-share profit trend, which aggregates annual net income and divides it by the number of shares, reflects the impact of these expenses on the base cost of capital, allowing investors to promptly identify a slowdown in the pace of capitalization.

Who Enliven Therapeutics competes with

GMAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year EXEL (Exelixis Corp)|NUVL (Nuvalent) - Net earnings per share for the last 12 months|KYMR: Earnings per share for the last four quarters|IDYA (IDEAYA Corp) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) oricpharma.com|Earnings per share for the last twelve months Relay Therapeutics, Inc. (RLAY)|NRIX (Nurix Therapeutics, Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) TYRA (Tyra Biosciences Inc)|Net earnings per share for the trailing year Verastem Inc|Monte Rosa Therapeutics Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cullinan Therapeutics, Inc.|IMRX (Immuneering Corporation) - Net earnings per share for the last 12 months|CCCC: Earnings per share for the last four quarters|BDTX (blackdiamondtherapeutics.com) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Repare Rx RPTX|Net earnings per share (EPS TTM) PMVP|Karyopharm - Earnings per share for the last 12 months|Propanc Biopharma Inc - Net earnings per share for the last 12 months|Earnings per share for the trailing year BGMS|AADI: Net earnings per share for the last 12 months|aileronrx.com - Earnings per share for the last four quarters|BPMC: Net earnings per share (EPS TTM)|GlycoMimetics Inc. - Earnings per share for the trailing year|SWTX (SpringWorks Therapeutics, Inc) - Net earnings per share (EPS TTM)